Chicken Soup for the Soul (CSSE) Acquires Redbox (RDBX) in All-Stock Deal
by Nicholas Alan Clayton on 2022-05-11 at 10:08am

Redbox (NASDAQ:RDBX) has agreed to be acquired by Chicken Soup for the Soul Entertainment (NASDSAQ:CSSE) in an all-stock deal just over six months after Redbox closed a SPAC deal with Seaport Global.

Redbox shareholders are to receive 0.087 Chicken Soup shares for each of their shares, which, at Chicken Soup’s Tuesday closing price would equate to a $0.689 per share offer. This is quite a concession as this is effectively an 88% discount on Redbox’s last closing price if $5.60. It has understandably plummeted 49% in early trading on news of the deal.

Chicken Soup is meanwhile up about 8.7% on in the on news of the deal, so the price may realign more in the favor of Redbox shareholders by the time the deal closes in the second half of 2022.

In the long-term, it may also provide a better future for Redbox shareholders. Illinois-based Redbox runs DVD-rental services out of about 38,000 physical kiosks in big box retail locations as well as a nascent streaming platform, and it may have had limited prospects given the changing technology and retail landscape around it.

By this point, Redbox’s most valuable assets were likely its physical space in these locations for marketing or sales of other goods as well as the customer book comprised of its roughly 40 million loyalty members. Its pivot to streaming was in the early goings and entailed stepping into a highly competitive arena.

Chicken Soup, meanwhile, has itself made a major transition from a popular line of branded books in the 90’s to a more diversified platform of videos on demand (VOD). The two companies might well have more value together than apart.

Redbox faced 85.9% redemptions when it closed in October 2021 at a time when the SPACs were averaging 59.7% shares redeemed on average for the month. The shareholders that remained will now own a 23.5% stake in the combined company, which is expected to have a run-rate of $500 million and $100 million to $150 million in adjusted EBITDA.

Redbox meanwhile reported $288 million in net revenue for an operating loss of $143 million in 2021. It also announced at the beginning of April that it was laying off 10% of its staff and had pulled the last $15 million available on its revolving credit facility.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved